Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124558895 | 12455889 | 5 | F | 20160811 | 20160610 | 20160822 | EXP | PHHY2016ZA073413 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160822 | MD | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124558895 | 12455889 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, UNK | 22068 | 200 | MG | CAPSULE | |||||||
| 124558895 | 12455889 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, UNK | 22068 | 400 | MG | CAPSULE | |||||||
| 124558895 | 12455889 | 3 | SS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, UNK | 22068 | 300 | MG | CAPSULE | |||||||
| 124558895 | 12455889 | 4 | SS | TASIGNA | NILOTINIB | 1 | Oral | 1 X 200 MG AM AND 2X200 MG PM (600 MG), QD | 22068 | 600 | MG | CAPSULE | QD | ||||||
| 124558895 | 12455889 | 5 | C | SLOW K | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 124558895 | 12455889 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124558895 | 12455889 | 1 | Chronic myeloid leukaemia |
| 124558895 | 12455889 | 5 | Product used for unknown indication |
| 124558895 | 12455889 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124558895 | 12455889 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124558895 | 12455889 | Dry eye | |
| 124558895 | 12455889 | Dry skin | |
| 124558895 | 12455889 | Feeling hot | |
| 124558895 | 12455889 | Gout | |
| 124558895 | 12455889 | Pain | |
| 124558895 | 12455889 | Peripheral swelling | |
| 124558895 | 12455889 | Skin disorder | |
| 124558895 | 12455889 | Tenderness | |
| 124558895 | 12455889 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124558895 | 12455889 | 1 | 201511 | 0 |